FSDC vs. ANL, ATAI, ANRO, ADCT, CRBP, PEPG, MREO, ORGO, NLTX, and HRTX
Should you be buying FS Development stock or one of its competitors? The main competitors of FS Development include Adlai Nortye (ANL), Atai Life Sciences (ATAI), Alto Neuroscience (ANRO), ADC Therapeutics (ADCT), Corbus Pharmaceuticals (CRBP), PepGen (PEPG), Mereo BioPharma Group (MREO), Organogenesis (ORGO), Neoleukin Therapeutics (NLTX), and Heron Therapeutics (HRTX). These companies are all part of the "medical" sector.
FS Development (NASDAQ:FSDC) and Adlai Nortye (NASDAQ:ANL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, community ranking, media sentiment, analyst recommendations, dividends and profitability.
Adlai Nortye received 4 more outperform votes than FS Development when rated by MarketBeat users.
89.8% of FS Development shares are owned by institutional investors. Comparatively, 35.2% of Adlai Nortye shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Adlai Nortye has a consensus price target of $30.00, indicating a potential upside of 181.69%. Given Adlai Nortye's higher possible upside, analysts clearly believe Adlai Nortye is more favorable than FS Development.
In the previous week, FS Development had 1 more articles in the media than Adlai Nortye. MarketBeat recorded 2 mentions for FS Development and 1 mentions for Adlai Nortye. Adlai Nortye's average media sentiment score of 1.94 beat FS Development's score of 0.00 indicating that Adlai Nortye is being referred to more favorably in the news media.
Summary
Adlai Nortye beats FS Development on 4 of the 6 factors compared between the two stocks.
Get FS Development News Delivered to You Automatically
Sign up to receive the latest news and ratings for FSDC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FSDC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
FS Development Competitors List
Related Companies and Tools